跳至主要内容
临床试验/IRCT20200429047235N3
IRCT20200429047235N3尚未招募3 期

The effect of astaxanthin supplementation on inflammatory markers, oxidative stress indices, lipid profile, uric acid level, blood pressure, endothelial function, quality of life and disease symptoms in heart failure subjects.

Esfahan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age 18 years and above
  • known heart failure in stage C, D based on American Heart Association(AHA) criteria and cardiologist diagnosis
  • Willingness to participate in the study and completion of the consent form

排除标准

  • Pregnancy and breastfeeding
  • Consumption of alcoholic beverages
  • Drug addiction
  • Suffering from uncontrolled diabetes
  • Use of herbal and medicinal supplements especially antioxidant supplements three months before starting the study
  • Warfarin drug use
  • Following a special diet or exercise program
  • Suffering from chronic liver, kidney and lung diseases
  • Suffering from chronic inflammatory diseases such as Crohn's and ulcerative colitis
  • Suffering from cancer
  • Suffering from acute coronary heart syndrome or heart surgery in the last 4 weeks.

研究者

相似试验